Stay updated on Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.

Latest updates to the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page
- Check2 days agoChange DetectedThe footer's revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to show a 403 error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-denied message and effectively hiding the study record and its related navigation.SummaryDifference20%

- Check44 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page metadata. No changes to the study details or results are reflected by this update.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page in the system.SummaryDifference0.0%

- Check80 days agoChange DetectedA new page revision identifier v3.6.4 was added, replacing the previous v3.6.3. This reflects a version update to the page’s documentation.SummaryDifference0.0%

- Check101 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a minor system update and does not change the study content.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.